Literature DB >> 15696458

Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary.

Matthew R Weir1, Jeffrey C Fink.   

Abstract

The relationship between sodium chloride (salt) intake and blood pressure and cardiovascular disease has been debated for decades. Overlooked is whether there is a relationship between dietary electrolyte ingestion (both sodium and potassium) and risk for progression of kidney disease, particularly in patients who manifest early evidence of chronic kidney disease (CKD). Patients with CKD often are salt sensitive and respond to increased ingestion of sodium chloride with increased blood pressure. Of concern is the clinical evidence that salt-sensitive patients respond to increased salt intake, in the physiological range, with increased glomerular filtration fraction and proteinuria. Thus, these salt-induced changes in both systemic blood pressure and the renal microcirculation create a favorable theoretical scenario for progressive renal injury. Increased salt intake also attenuates the antihypertensive effects of most antihypertensive drugs. Consequently, salt intake must be considered a potential modifiable risk factor for the progression of kidney disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15696458     DOI: 10.1053/j.ajkd.2004.08.041

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  19 in total

1.  President's address: salt-too much of a good thing?

Authors:  Robert G Luke
Journal:  Trans Am Clin Climatol Assoc       Date:  2007

2.  A Salt-Induced Reno-Cerebral Reflex Activates Renin-Angiotensin Systems and Promotes CKD Progression.

Authors:  Wei Cao; Aiqing Li; Liangliang Wang; Zhanmei Zhou; Zhengxiu Su; Wei Bin; Christopher S Wilcox; Fan Fan Hou
Journal:  J Am Soc Nephrol       Date:  2015-01-29       Impact factor: 10.121

Review 3.  Nutritional treatment in chronic kidney disease: the concept of nephroprotection.

Authors:  Eleonora Riccio; Antonella Di Nuzzi; Antonio Pisani
Journal:  Clin Exp Nephrol       Date:  2014-10-16       Impact factor: 2.801

Review 4.  Kidney disease and obesity: epidemiology, mechanisms and treatment.

Authors:  Niels Olsen Saraiva Câmara; Kunitoshi Iseki; Holly Kramer; Zhi-Hong Liu; Kumar Sharma
Journal:  Nat Rev Nephrol       Date:  2017-01-16       Impact factor: 28.314

5.  Association of filtered sodium load with medullary volumes and medullary hypoxia in hypertensive African Americans as compared with whites.

Authors:  Stephen C Textor; Monika L Gloviczki; Michael F Flessner; David A Calhoun; James Glockner; Joseph P Grande; Michael A McKusick; Stephen S Cha; Lilach O Lerman
Journal:  Am J Kidney Dis       Date:  2011-11-29       Impact factor: 8.860

6.  Renal histopathological findings in relation to ambulatory blood pressure in chronic kidney disease patients.

Authors:  Kotaro Haruhara; Nobuo Tsuboi; Kentaro Koike; Akira Fukui; Yoichi Miyazaki; Tetsuya Kawamura; Makoto Ogura; Takashi Yokoo
Journal:  Hypertens Res       Date:  2014-09-18       Impact factor: 3.872

7.  Diet and Chronic Kidney Disease.

Authors:  Holly Kramer
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

8.  Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.

Authors:  Jussara M do Carmo; Lakshmi S Tallam; John V Roberts; Elizabeth L Brandon; John Biglane; Alexandre A da Silva; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-15       Impact factor: 3.619

Review 9.  Application of direct renin inhibition to chronic kidney disease.

Authors:  Christian W Mende
Journal:  Cardiovasc Drugs Ther       Date:  2010-04       Impact factor: 3.727

10.  Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.

Authors:  Georges N Nakhoul; Haiquan Huang; Susana Arrigain; Stacey E Jolly; Jesse D Schold; Joseph V Nally; Sankar D Navaneethan
Journal:  Am J Nephrol       Date:  2015-07-25       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.